Bellerophon Therapeutics, Inc.·4

Jan 17, 5:00 PM ET

Shah Parag Suresh 4

4 · Bellerophon Therapeutics, Inc. · Filed Jan 17, 2018

Insider Transaction Report

Form 4
Period: 2018-01-12
Shah Parag Suresh
VP Proj Mgmt & Distribution
Transactions
  • Award

    Common Stock

    2018-01-12+20,69060,238 total
  • Award

    Stock Option (right to buy)

    2018-01-12+80,00080,000 total
    Exercise: $2.03Exp: 2028-01-12Common Stock (80,000 underlying)
Footnotes (1)
  • [F1]This option was granted on January 12, 2018. This option vests in quarterly installments over a four-year period from the date of grant.

Documents

1 file
  • 4
    wf-form4_151622638582976.xmlPrimary

    FORM 4